ResMed Management Performance Evaluation

RMD -- USA Stock  

USD 108.52  0.86  0.79%

Analysis of ResMed manpower and management performance can provide insight into ResMed stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with ResMed future performance. Additionally take a look at Your Equity Center.

ResMed Management Effectiveness

The company has Return on Asset of 9.58 % which means that on every $100 spent on asset it made $9.58 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.68 % implying that it generated $15.68 on every 100 dollars invested.

ResMed Workforce Comparison

ResMed is rated third in number of employees category among related companies. The total workforce of Medical Equipment industry is at this time estimated at about 80,459. ResMed holds roughly 6,000 in number of employees claiming about 7% of all equities under Medical Equipment industry.

ResMed Profit Margins

The company has Net Profit Margin of 13.52 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 28.58 % which entails that for every 100 dollars of revenue it generated 0.29 of operating income.

ResMed Insider Trading

ResMed Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of seventeen. ResMed Price Series Summation is a cross summation of ResMed price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

ResMed Stakeholders

Michael Farrell CEO and Director, MBA
Peter Farrell Non-Executive Chairman of the Board, Ph.D
Rob Douglas President COO
Jim Hollingshead President - Americas, Ph.D
Don Darkin President - Sleep-disordered Breathing Strategic Business Unit
Anne Reiser President Europe
Raj Sodhi President ? Software as a Service (SaaS) Business and CTO, MBA
Richard McHale President ? Respiratory Care
Donald Darkin President ? innovation & operations
Brett Sandercock CFO and Principal Accounting Officer
Robert Douglas Pres and COO
John Wareham Independent Director, MBA
Ronald Taylor Lead Independent Director
Christopher Roberts Independent Director, MBA
Gary Pace Independent Director, Ph.D
Chris Roberts Independent Director, MBA
Agnes Lee Senior Director - Investor Relations
Carol Burt Independent Director
Rich Sulpizio Independent Director
Ron Taylor Lead Independent Director
Jack Wareham Independent Director
Karen Drexler Director
Richard Sulpizio Independent Director
David Pendarvis Chief Admin. Officer, Global General Counsel and Secretary

Leadership

ResMed Top Executives
  Michael Farrell  CEO
CEO and Director
  Peter Farrell  Chairman
Non-Executive Chairman of the Board

ResMed Employment Tenure

ResMed employes about 6000 people. The company is managed by 24 executives with total tenure of roughly 157 years, averanging almost 6.0 years of service per executive having 250.0 employee per reported executive.

Return on ResMed Manpower

Revenue Per Employee 410.9 K
Revenue Per Executive 94.6 M
Net Income Per Employee 78.8 K
Net Income Per Executive 12.8 M
Working Capital Per Employee 130.3 K
Working Capital Per Executive 32.6 M

Per Employee

ResMed Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

Additionally take a look at Your Equity Center. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.